Blog
FDA Releases Outline of Guidance for Developing Tests Based on Human Genetic Variants
Blog
Rapid Litigation v. CellzDirect – A Break in the 101 Wall
Blog
Bascom v. AT&T — Patent Eligibility Meet Patentability
Blog
USPTO will "Fast Track" Cancer Immunotherapy Applications
Blog
Exergen Corp. v. Thermomedics, Inc. – How to Flunk s. 101
Blog
Same-Day Continuing Applications are Co-pending under s. 120
Blog
“Unclean Hands” Doctrine Erases Merck’s Damage Award
Blog
Supreme Court Rewrites the Law of Enhanced Damages
Blog
Merck’s Solvaldi® Patents Unenforceable for Egregious Misconduct
Blog
Due May 24 — Comments On Improving Patent Quality Metrics
Blog
New (and Improved?) PTO Guidelines on Biotech Patent-Eligibility
Blog